Juan Carlos Jorge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Juan Carlos Jorge has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Azarhí Fortis
Department of Chemistry, Rio Piedras Campus, University of Puerto Rico, San Juan 00936, Puerto Rico
1 shared publicationCarolina Echeverri
School of Medicine, University of Puerto Rico , San Juan , Puerto Rico
1 shared publication- Jeffrey Parrilla-Carrero
Department of Neuroscience, Medical University of South Carolina, Charleston, SC 29425, USA
1 shared publication Jennifer L. Barreto-Estrada
University of Puerto Rico School of Medicine--Anatomy, San Juan, Puerto Rico
1 shared publicationJuan Carlos Rivera-Arce
Ponce School of Medicine, Rio Piedras Campus, Puerto Rico
1 shared publicationKandy T. Velázquez
Department of Physiology, Medical Sciences Campus, University of Puerto Rico, San Juan 00936, Puerto Rico
1 shared publication
Latest Publications
- 1 January 2008
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 5 (1) , 122-131
Male Gender Identity in an XX Individual with Congenital Adrenal Hyperplasia
Introduction: In spite of significant changes in the management policies of intersexuality, clinical evidence show that not all pubertal or adult individuals live according to the assigned sex during infancy. Aim: The purpose of this study was to analyze the clinical management of an individual diagnosed as a female pseudohermaphrodite with congenital adrenal hyperplasia (CAH) simple virilizing form four decades ago but who currently lives as a monogamous heterosexual male. Methods: We studied the clinical files spanning from 1965 to 1991 of an intersex individual. In addition, we conducted a magnetic resonance imaging (MRI) study of the abdominoplevic cavity and a series of interviews using the oral history method. Main Outcome Measures: Our analysis is based on the clinical evidence that led to the CAH diagnosis in the 1960s in light of recent clinical testing to confirm such diagnosis. Results: Analysis of reported values for 17-ketosteroids, 17-hydroxycorticosteroids, from 24-hour urine samples during an 8-year period showed poor adrenal suppression in spite of adherence to treatment. A recent MRI study confirmed the presence of hyperplastic adrenal glands as well as the presence of a prepubertal uterus. Semistructured interviews with the individual confirmed a life history consistent with a male gender identity. Conclusions: Although the American Academy of Pediatrics recommends that XX intersex individuals with CAH should be assigned to the female sex, this practice harms some individuals as they may self-identify as males. In the absence of comorbid psychiatric factors, the discrepancy between infant sex assignment and gender identity later in life underlines the need for a reexamination of current standards of care for individuals diagnosed with CAH.
- 1 January 2008
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 5 (1) , 122-131
Male Gender Identity in an XX Individual with Congenital Adrenal Hyperplasia
Introduction: In spite of significant changes in the management policies of intersexuality, clinical evidence show that not all pubertal or adult individuals live according to the assigned sex during infancy. Aim: The purpose of this study was to analyze the clinical management of an individual diagnosed as a female pseudohermaphrodite with congenital adrenal hyperplasia (CAH) simple virilizing form four decades ago but who currently lives as a monogamous heterosexual male. Methods: We studied the clinical files spanning from 1965 to 1991 of an intersex individual. In addition, we conducted a magnetic resonance imaging (MRI) study of the abdominoplevic cavity and a series of interviews using the oral history method. Main Outcome Measures: Our analysis is based on the clinical evidence that led to the CAH diagnosis in the 1960s in light of recent clinical testing to confirm such diagnosis. Results: Analysis of reported values for 17-ketosteroids, 17-hydroxycorticosteroids, from 24-hour urine samples during an 8-year period showed poor adrenal suppression in spite of adherence to treatment. A recent MRI study confirmed the presence of hyperplastic adrenal glands as well as the presence of a prepubertal uterus. Semistructured interviews with the individual confirmed a life history consistent with a male gender identity. Conclusions: Although the American Academy of Pediatrics recommends that XX intersex individuals with CAH should be assigned to the female sex, this practice harms some individuals as they may self-identify as males. In the absence of comorbid psychiatric factors, the discrepancy between infant sex assignment and gender identity later in life underlines the need for a reexamination of current standards of care for individuals diagnosed with CAH.
- 1 July 2007
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 4 (4_Part_1) , 878-885
Exposure to an Anabolic Steroid Changes Female Mice's Sexual Responses According to Sex Partner
Introduction: Anabolic androgenic steroids (AAS) affect human female sexual behaviors. Animal models have been useful in uncovering the neural mechanisms governing changes in female sexual response upon AAS exposure.Aim: We quantify the sexual response of AAS-exposed gonadally intact female mice when paired with gonadally intact female or male pairs.Methods: C57Bl/6 female mice were systemically exposed to the AAS 17α-methyltestosterone (7.5 mg/kg) for 17 days via a subcutaneous osmotic implant. On days 15–17, these females were allowed to mate with males or proestrus female partners in familiar and unfamiliar testing arenas for 10 minutes.Main Outcome Measures: The following behavioral responses were registered: parameters related to mounting behavior such as the frequency of mounts, attempts to mount, and the latency to the first mount, anogenital investigation, fights and escapes, rejections, pelvic thrusts, and lordotic responses.Results: We found that males displayed a significant decrease in the frequency of mounts to AAS-exposed females, when compared with mating encounters with control females. We found no difference in the lordosis strength when control females were mounted by either a male or AAS-exposed females. However, females under androgen exposure attempted to mount control females, but not males, and their behavior was accompanied by significant increases in the number of fights, escapes, and rejections to the male. There were no differences between AAS-exposed females and males when the frequency of mounts and pelvic thrusts toward control females were compared. The lordotic quotient of control females was similar for either partner.Conclusions: Aside from showing a male-like pattern, AAS-exposed females displayed a higher frequency of anogenital investigations toward control females than males, and their latency to the first mount was as fast as that of males. Taken together, we conclude that the sex partner greatly influences the sexual response of AAS-exposed female mice.
- 1 July 2007
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 4 (4_Part_1) , 878-885
Exposure to an Anabolic Steroid Changes Female Mice's Sexual Responses According to Sex Partner
Introduction: Anabolic androgenic steroids (AAS) affect human female sexual behaviors. Animal models have been useful in uncovering the neural mechanisms governing changes in female sexual response upon AAS exposure.Aim: We quantify the sexual response of AAS-exposed gonadally intact female mice when paired with gonadally intact female or male pairs.Methods: C57Bl/6 female mice were systemically exposed to the AAS 17α-methyltestosterone (7.5 mg/kg) for 17 days via a subcutaneous osmotic implant. On days 15–17, these females were allowed to mate with males or proestrus female partners in familiar and unfamiliar testing arenas for 10 minutes.Main Outcome Measures: The following behavioral responses were registered: parameters related to mounting behavior such as the frequency of mounts, attempts to mount, and the latency to the first mount, anogenital investigation, fights and escapes, rejections, pelvic thrusts, and lordotic responses.Results: We found that males displayed a significant decrease in the frequency of mounts to AAS-exposed females, when compared with mating encounters with control females. We found no difference in the lordosis strength when control females were mounted by either a male or AAS-exposed females. However, females under androgen exposure attempted to mount control females, but not males, and their behavior was accompanied by significant increases in the number of fights, escapes, and rejections to the male. There were no differences between AAS-exposed females and males when the frequency of mounts and pelvic thrusts toward control females were compared. The lordotic quotient of control females was similar for either partner.Conclusions: Aside from showing a male-like pattern, AAS-exposed females displayed a higher frequency of anogenital investigations toward control females than males, and their latency to the first mount was as fast as that of males. Taken together, we conclude that the sex partner greatly influences the sexual response of AAS-exposed female mice.
- 1 June 2006
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 84 (2) , 275-281
Central effects of the anabolic steroid 17α methyltestosterone in female anxiety
- 1 June 2006
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 84 (2) , 275-281
Central effects of the anabolic steroid 17α methyltestosterone in female anxiety
- 17 January 2005
- Published by Elsevier in Physiology & Behavior
- Vol. 83 (5) , 779-786
Sex-specific modulation of anxiety and locomotion after neonatal exposure to pregnenolone sulfate
- 17 January 2005
- Published by Elsevier in Physiology & Behavior
- Vol. 83 (5) , 779-786
Sex-specific modulation of anxiety and locomotion after neonatal exposure to pregnenolone sulfate